Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease

Stock Information for Mereo BioPharma Group plc

Loading

Please wait while we load your information from QuoteMedia.